Rare diseases
Investigational molecules
Locations
Back to Romania71 clinical trials in Constanta, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)RomaniaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
RomaniaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
RomaniaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
RomaniaA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
RomaniaA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
RomaniaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
RomaniaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
RomaniaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
RomaniaStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
RomaniaStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
RomaniaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on multiple sclerosis treatments, including studies of remibrutinib and tolebrutinib for both relapsing and progressive forms. Additional trials investigate therapies for myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.
Studies aim to evaluate long-term safety and efficacy of novel therapeutic approaches.
Comprehensive research into viral infections, including studies on COVID-19 treatments and HIV-1 management. Trials evaluate new therapeutic options for respiratory syncytial virus (RSV) prevention in infants.
Focus on developing both treatment and preventive strategies for viral diseases.
Studies investigating treatments for Sjögren's Disease and inflammatory bowel conditions like Crohn's Disease. Research includes evaluation of novel therapies such as mirikizumab and MORF-057.
Trials focus on improving disease management and patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
